Perfect ALKemy: Optimizing the Use of ALK-Directed Therapies in Lung Cancer

Por Politi, Katerina, Gettinger, Scott
Publicado no Clin Cancer Res (2014)

PD-1 axis inhibitors in EGFR and ALK Driven Lung Cancer: Lost cause?

Por Gettinger, Scott, Politi, Katerina
Publicado no Clin Cancer Res (2016)

Current status of vandetanib (ZD6474) in the treatment of non-small cell lung cancer

Por Flanigan, Jaclyn, Deshpande, Hari, Gettinger, Scott
Publicado em 2010

Axitinib: The evidence of its potential in the treatment of advanced thyroid cancer

Por Deshpande, Hari A, Gettinger, Scott, Sosa, Julie Ann
Publicado em 2010

Immuno-thermal ablations – boosting the anticancer immune response

Por Slovak, Ryan, Ludwig, Johannes M., Gettinger, Scott N., Herbst, Roy S., Kim, Hyun S.
Publicado no J Immunother Cancer (2017)

Late recurrence of basaloid carcinoma initially treated as a small cell lung cancer

Por Shumaster, Vladimir, Bae, Jason W., Gettinger, Scott N., Cai, Guoping, Kim, Anthony W.
Publicado em 2013

SOX2-specific adaptive immunity and response to immunotherapy in non-small cell lung cancer

Por Dhodapkar, Kavita M, Gettinger, Scott N, Das, Rituparna, Zebroski, Henry, Dhodapkar, Madhav V
Publicado em 2013

Oncolytic virus immunotherapy: future prospects for oncology

Por Raja, Junaid, Ludwig, Johannes M., Gettinger, Scott N., Schalper, Kurt A., Kim, Hyun S.
Publicado no J Immunother Cancer (2018)

Precipitation of Autoimmune Diabetes With Anti-PD-1 Immunotherapy

Por Hughes, Jing, Vudattu, Nalini, Sznol, Mario, Gettinger, Scott, Kluger, Harriet, Lupsa, Beatrice, Herold, Kevan C.
Publicado no Diabetes Care (2015)

Cryotherapy for nodal metastasis in NSCLC with acquired resistance to immunotherapy

Por Adam, Lucas C., Raja, Junaid, Ludwig, Johannes M., Adeniran, Adebowale, Gettinger, Scott N., Kim, Hyun S.
Publicado no J Immunother Cancer (2018)

Distinct immunologic changes in vivo following combination versus individual PD-1 or CTLA-4 checkpoint blockade in human cancer

Por Dhodapkar, Kavita, Verma, Rakesh, Sznol, Mario, Boddupalli, Chandra Sekhar, Gettinger, Scott, Kluger, Harriet, Dhodapkar, Madhav, Das, Rituparna
Publicado no J Immunother Cancer (2014)

An Advanced Practice Nurse Coordinated Multidisciplinary Intervention for Patients with Late-Stage Cancer: A Cluster Randomized Trial

Por McCorkle, Ruth, Jeon, Sangchoon, Ercolano, Elizabeth, Lazenby, Mark, Reid, Amanda, Davies, Marianne, Viveiros, Diane, Gettinger, Scott
Publicado no J Palliat Med (2015)

Preliminary safety, pharmacokinetics, and efficacy of regorafenib, cisplatin, and pemetrexed in patients with advanced non-squamous non-small cell lung cancers

Por Hellmann, Matthew D, Sturm, Isrid, Trnkova, Zuzana Jirakova, Lettieri, John, Diefenbach, Konstanze, Rizvi, Naiyer A., Gettinger, Scott N.
Publicado no Clin Lung Cancer (2015)

Expression and clinical significance of PD-L1, B7-H3, B7-H4 and TILs in human small cell lung Cancer (SCLC)

Por Carvajal-Hausdorf, Daniel, Altan, Mehmet, Velcheti, Vamsidhar, Gettinger, Scott N., Herbst, Roy S., Rimm, David L., Schalper, Kurt A.
Publicado no J Immunother Cancer (2019)

Comparison of Survival Rates After a Combination of Local Treatment and Systemic Therapy vs Systemic Therapy Alone for Treatment of Stage IV Non–Small Cell Lung Cancer

Por Uhlig, Johannes, Case, Meaghan Dendy, Blasberg, Justin D., Boffa, Daniel J., Chiang, Anne, Gettinger, Scott N., Kim, Hyun S.
Publicado no JAMA Netw Open (2019)

Biomarkers associated with beneficial PD-1 checkpoint blockade in non-small-cell lung cancer (NSCLC) identified using high-plex digital spatial profiling

Por Zugazagoitia, Jon, Gupta, Swati, Liu, Yuting, Fuhrman, Kit, Gettinger, Scott, Herbst, Roy, Schalper, Kurt A., Rimm, David L.
Publicado no Clin Cancer Res (2020)

High SOX2 Levels Predict Better Outcome in Non-Small Cell Lung Carcinomas

Por Velcheti, Vamsidhar, Schalper, Kurt, Yao, Xiaopan, Cheng, Huan, Kocoglu, Mehmet, Dhodapkar, Kavita, Deng, Yanhong, Gettinger, Scott, Rimm, David L.
Publicado em 2013

Treatment of Stage IV Non-small Cell Lung Cancer: Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

Por Socinski, Mark A., Evans, Tracey, Gettinger, Scott, Hensing, Thomas A., VanDam Sequist, Lecia, Ireland, Belinda, Stinchcombe, Thomas E.
Publicado no Chest (2013)

Immune-related sarcoidosis observed in combination ipilimumab and nivolumab therapy

Por Suozzi, Kathleen C., Stahl, Maximilian, Ko, Christine J., Chiang, Anne, Gettinger, Scott N., Siegel, Mark D., Bunick, Christopher G.
Publicado no JAAD Case Rep (2016)

Clinical and Histologic Features of Lichenoid Mucocutaneous Eruptions Due to Anti–Programmed Cell Death 1 and Anti–Programmed Cell Death Ligand 1 Immunotherapy

Por Shi, Veronica J., Rodic, Nemanja, Gettinger, Scott, Leventhal, Jonathan S., Neckman, Julia P., Girardi, Michael, Bosenberg, Marcus, Choi, Jennifer N.
Publicado no JAMA Dermatol (2016)